c19development

SPRINGDALE, Ark., Dec. 7, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that study results for its ADEXUSDx® COVID-19 antibody test yielded encouraging test performance—providing a strong use case for the innovative diagnostic device, which was filed for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on May 29, 2020. The antibody test  delivered 100 percent sensitivity and

Whether one has long-term immunity to COVID-19 after recovering from the virus is unclear amid a lack of scientific evidence. Still, antibodies might be the key to develop a vaccine and prevent virus reinfection. Two Northwest Arkansas companies have developed tests to detect the presence of virus antibodies. Fayetteville-based Namida Lab Inc. has offered antibody,

FAYETTEVILLE, Ark. (KNWA/KFTA) — Northwest Arkansans can get paid for participating in a COVID-19 study. Now-Diagnostics is asking Washington and Benton County residents to participate in its new COVID-19 diagnostic tests. Now-Diagnostics is sponsoring a clinical study collecting saliva to develop one antigen and one antibody COVID-19 diagnostics test. Interested in learning more? Read full

University of Milan Study Finds Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Test has 100% Specificity  Independent study confirms revolutionary technology provides accurate results in minutes while requiring no additional reagents or equipment. SPRINGDALE, AR, October 12, 2020 – NOWDiagnostics, Inc. announced today that an independent validation study of the ADEXUSDx® COVID-19 antibody test conducted by the university